[Flash] Moderna Stock Surges 14% on Hantavirus Vaccine Prospect
Moderna (MRNA) shares jumped 14% as investors reacted positively to the company’s hantavirus vaccine development. The surge comes amid global attention on the hantavirus cruise ship outbreak, with investors optimistic about the vaccine’s commercial potential. Analysts advise monitoring clinical trial progress.
Source: Google News